Mohamed S Alesawy

9PUBLICATIONS
11CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 09, 2023
Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach.

Ibrahim H Eissa, Reda G Yousef, Eslam B Elkaeed

|Sep 23, 2022
Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach.

Eslam B Elkaeed, Ahmed M Metwaly, Mohamed S Alesawy

|Apr 12, 2022
Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs.

Ibrahim H Eissa, Mohamed S Alesawy, Abdulrahman M Saleh

|Mar 16, 2022
Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations.

Khaled El-Adl, Mohamed-Kamal Ibrahim, Mohamed S Alesawy

|Feb 23, 2022
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking.

Ibrahim H Eissa, Mohamed-Kamal Ibrahim, Mohamed S Alesawy

|Jan 11, 2022
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3-c]quinazolines as classical DNA intercalators.

Mohamed S Alesawy, Mohamed-Kamal Ibrahim, Ibrahim H Eissa

Pageof 2

Frequent Collaborators

8 joint publications

Ibrahim H Eissa

5 joint publications

Eslam B Elkaeed

4 joint publications

Ahmed M Metwaly

3 joint publications

Aisha A Alsfouk